Biovet
Animal-health vaccine manufacturer based in Malur, Karnataka, operating a high-containment facility (BSL-3+/Ag) for large-animal vaccine production. In-house R&D develops vaccines, diagnostics and monoclonal antibodies for livestock diseases, with manufacturing and quality systems aligned to OIE/WHO/GMP standards and partnerships with national research institutes.
Industries
Nr. of Employees
small (1-50)
Biovet
Plot No.308, 3rd Phase KIADB Industrial Area, Malur Taluk, Kolar Dist., Karnataka, India
Patents
Production procedure for Alquernat Coneb, a functional feed based on alliin, carvacrol, cimenol and inulin from vegetable extracts, to be used in the prevention of parasitic infestations in poultry feed
US-11938107-B1
View DetailsProduction procedure for a functional feed based in ellagic acid, cimenol and alliin from vegetable extracts to be used as pronutrient in animal feed
US-10111449-B2
View Details
Production procedure for Alquernat Coneb, a functional feed based on alliin, carvacrol, cimenol and inulin from vegetable extracts, to be used in the prevention of parasitic infestations in poultry feed
US-11938107-B1
View DetailsProduction procedure for a functional feed based in ellagic acid, cimenol and alliin from vegetable extracts to be used as pronutrient in animal feed
US-10111449-B2
View DetailsProducts
Inactivated oil-emulsion vaccine for foot-and-mouth disease (FMD)
Inactivated oil-emulsion vaccine for prevention of foot-and-mouth disease in livestock; intramuscular administration with defined dosing and booster schedule; refrigerated storage.
Bluetongue disease vaccines (oil and gel formulations)
Vaccines formulated as oil-emulsion and gel presentations for prevention of bluetongue disease in sheep and goats; subcutaneous administration with recommended schedules and refrigerated storage.
Haemorrhagic septicaemia and combined HS–Black Quarter vaccines
Oil-emulsion and gel vaccines for prevention of haemorrhagic septicaemia and combined haemorrhagic septicaemia–black quarter disease in cattle and buffalo; subcutaneous administration and refrigerated storage.
Johne’s disease vaccine (oil and gel formulations)
Vaccines for prevention of Johne's disease in cattle, buffalo, sheep and goats; subcutaneous administration and age-based dosing schedules.
Black quarter disease vaccine
Gel-based vaccine for prevention of black quarter disease in cattle and buffalo; subcutaneous administration and annual revaccination recommended.
Enterotoxemia vaccine (gel formulation)
Gel vaccine for prevention of enterotoxemia in sheep and goats; subcutaneous administration and annual revaccination.
Inactivated oil-emulsion vaccine for foot-and-mouth disease (FMD)
Inactivated oil-emulsion vaccine for prevention of foot-and-mouth disease in livestock; intramuscular administration with defined dosing and booster schedule; refrigerated storage.
Bluetongue disease vaccines (oil and gel formulations)
Vaccines formulated as oil-emulsion and gel presentations for prevention of bluetongue disease in sheep and goats; subcutaneous administration with recommended schedules and refrigerated storage.
Haemorrhagic septicaemia and combined HS–Black Quarter vaccines
Oil-emulsion and gel vaccines for prevention of haemorrhagic septicaemia and combined haemorrhagic septicaemia–black quarter disease in cattle and buffalo; subcutaneous administration and refrigerated storage.
Johne’s disease vaccine (oil and gel formulations)
Vaccines for prevention of Johne's disease in cattle, buffalo, sheep and goats; subcutaneous administration and age-based dosing schedules.
Black quarter disease vaccine
Gel-based vaccine for prevention of black quarter disease in cattle and buffalo; subcutaneous administration and annual revaccination recommended.
Enterotoxemia vaccine (gel formulation)
Gel vaccine for prevention of enterotoxemia in sheep and goats; subcutaneous administration and annual revaccination.
Expertise Areas
- Veterinary vaccine development
- High-containment animal vaccine manufacturing
- Vaccine formulation and fill–finish
- Vaccine quality control and analytical testing
Key Technologies
- BSL-3/Ag biocontainment systems
- Viral fermentation and cell-culture antigen production
- Antigen concentration and banking
- Oil-emulsion and gel vaccine formulation
News & Updates
Media coverage of planned investment to expand vaccine manufacturing capacity at the Malur facility.
News article covering company investment plans in animal vaccine manufacturing.
Announcement of expansion of FMD vaccine manufacturing capacity with investment details.
Press coverage of planned large-scale vaccine production facilities.
Recipient of a national technology award presented by the President of India.
Claimed operation of a high-containment BSL-3 plus agricultural production facility for animal vaccines.
Media coverage of planned investment to expand vaccine manufacturing capacity at the Malur facility.
News article covering company investment plans in animal vaccine manufacturing.
Announcement of expansion of FMD vaccine manufacturing capacity with investment details.
Press coverage of planned large-scale vaccine production facilities.
Recipient of a national technology award presented by the President of India.
Claimed operation of a high-containment BSL-3 plus agricultural production facility for animal vaccines.